ANTIBIOTICE IASI
78 articole · RSS
Antibiotice Iasi Seeks Shareholder Approval For Up To RON250M Non-Recourse Factoring Facility From Banca Transilvania
Pharmaceutical manufacturer Antibiotice Iasi (stock symbol: ATB), controlled by the Ministry of Health, has convened its shareholders for December 17 to approve a non-recourse factoring facility of up to RON250 million (EUR47 million) from lender Banca Transil...
Antibiotice Reports RON15.5M Profit in H1/2026, Down 74% YOY
Romanian owned drug producer Antibiotice Iasi posted a RON15.5 million net profit in the first half of 2026, 74% below the year-earlier level.
Antibiotice Iasi Strengthens Its International Growth: Sales Increase In The US, Entry Into Spanish Market
Antibiotice Iasi (stock symbol: ATB), the largest Romanian owned drug maker, on Friday (June 5) released a report containing new details regarding its international expansion strategy, as it...
Antibiotice Iasi Posts 61% Lower Net Profit Of RON12.5M YoY In Q1/2026
Antibiotice Iasi (stock symbol: ATB), the largest Romanian owned drug maker, ended the first quarter of 2026 with net profit of RON12.5 million, down 61.5% on the year, amid the contraction...
Antibiotice Iasi Secures EUR67M Loan From Banca Transilvania To Speed Up Strategic Investments
Antibiotice Iasi (stock symbol: ATB), the largest Romanian owned drug maker, continues to develop several strategic projects for the pharmaceutical industry through a EUR67 million in fundin...
Antibiotice Iasi Gets 40% of Business From Exports
Antibiotice Iasi, the largest Romanian owned drug maker, has steadily boosted its exports, with 41% of turnover coming from sales abroad in 2025, namely RON266 million.
Antibiotice Iasi Has Two Dividend Proposals: of 50% and 90% of 2025 Profit
Drug manufacturer Antibiotice Iasi has presented its shareholders with two dividend proposals depending on the Government’s decision regarding its being exempted from the mandatory distribut...
Antibiotice Iasi 2025 Gross Profit Plunges 42% YoY To RON60.1M
Romanian-owned drug producer Antibiotice Iasi (stock symbol: ATB) ended 2025 with a preliminary gross profit of RON60.1 million, down 42% year-over-year, the company said in its financial re...
Antibiotice Iasi Predicts Lower Revenue, Lower-Than-Expected Operating Margins For 2025 Fiscal Year
Romanian-owned drug producer Antibiotice Iasi (stock symbol: ATB) published the preliminary data regarding the key performance indicators for the 2025 fiscal year, which show weaker results...